RADNOR, Pa., April 09, 2025 (GLOBE NEWSWIRE) -- The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that a securities class action lawsuit has been filed in the United States District Court for the District of Massachusetts against TransMedics Group, Inc. (“TransMedics”) (NASDAQ: TMDX) on behalf of those who purchased or otherwise acquired TransMedics securities between February 28, 2023, and January 10, 2025, inclusive (the “Class Period”). The lead plaintiff deadline is Apr ...

Core Viewpoint - Rosen Law Firm is reminding investors who purchased TransMedics Group, Inc. securities during the specified Class Period of the upcoming lead plaintiff deadline for a securities class action lawsuit [1][2]. Group 1: Class Action Details - The Class Period for the TransMedics securities class action is from February 28, 2023, to January 10, 2025 [1]. - Investors may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [2]. - A lead plaintiff must file a motion with the Court by April 15, 2025, to represent other class members in the litigation [3]. Group 2: Allegations Against TransMedics - The lawsuit alleges that TransMedics made materially false and misleading statements, including the use of kickbacks, fraudulent overbilling, and coercive tactics to generate revenue [5]. - It is claimed that TransMedics engaged in unsafe practices and concealed safety issues, leading to increased regulatory scrutiny [5]. - The misleading statements about the company's business and operations resulted in investor damages when the truth was revealed [5]. Group 3: Rosen Law Firm's Credentials - Rosen Law Firm has a strong track record in securities class actions, having achieved the largest settlement against a Chinese company at the time [4]. - The firm was ranked No. 1 for the number of securities class action settlements in 2017 and has consistently ranked in the top 4 since 2013 [4]. - In 2019, the firm secured over $438 million for investors, showcasing its capability in recovering significant amounts for clients [4].

SAN DIEGO, April 8, 2025 /PRNewswire/ -- The law firm of Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of TransMedics Group, Inc. (NASDAQ: TMDX) publicly traded securities between February 28, 2023 and January 10, 2025, both dates inclusive (the "Class Period"), have until Tuesday, April 15, 2025 to seek appointment as lead plaintiff of the TransMedics class action lawsuit.  Captioned Jewik v. TransMedics Group, Inc., No. 25-cv-10385 (D. Mass.), the TransMedics class action lawsuit ...

PHILADELPHIA, April 8, 2025 /PRNewswire/ -- A securities class action lawsuit has been filed against Transmedics Group, Inc. ("TransMedics" or the "Company") (NASDAQ: TMDX). The lawsuit has been filed on behalf of purchasers of TransMedics securities between February 28, 2023 and January 10, 2025, inclusive (the "Class Period").CLICK HERE TO LEARN MORE ABOUT THIS LAWSUIT.Investors who purchased or acquired Transmedics Group, Inc. securities during the Class Period may, no later than APRIL 15, 2025, seek to ...

SAN FRANCISCO, April 08, 2025 (GLOBE NEWSWIRE) -- TransMedics Group, Inc. (NASDAQ: TMDX) reported blockbuster Q4 2024 earnings in late February 2025, booking $121.6 million in revenue (up 50% year-over-year) and $35.5 million in full-year net income, fueled by surging adoption of its OCS devices. Despite these positive results, TMDX stock continues to trade significantly below its 2024 highs, as the earnings report arrives amid explosive allegations from short-seller Scorpion Capital and mounting legal chal ...

Core Viewpoint - A securities class action lawsuit has been filed against TransMedics Group, alleging misleading statements and illegal business practices that negatively impacted the company's financial performance and stock price [1][3]. Group 1: Lawsuit Details - The lawsuit was filed by Scott+Scott Attorneys at Law LLP in the U.S. District Court for the District of Massachusetts, asserting claims under the Securities Exchange Act of 1934 [1]. - The class period for the lawsuit spans from February 28, 2023, to January 10, 2025, covering all individuals who purchased TransMedics securities during this time [1][6]. Group 2: Allegations Against TransMedics - Defendants are accused of failing to disclose reliance on illegal and coercive business practices, including kickbacks, billing fraud, and overcharging patients, which led to a decline in customer usage and increased regulatory scrutiny [3]. - The lawsuit highlights a significant decline in revenues and gross margin reported by TransMedics in Q3 2024, marking the first sequential revenue decline since Q3 2021, resulting in a nearly 30% drop in stock price [4]. Group 3: Impact on Stock Price - Following the release of a report by Scorpion Capital on January 10, 2025, which accused TransMedics of overbilling hospitals, the stock price fell by $3.74 per share (5.15%) to close at $68.81 [5]. - On January 13, 2025, the stock experienced a further decline of $4.76 per share (6.9%), closing at $64.05 [5].

NEW YORK, April 8, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in TransMedics Group, Inc. ("TransMedics" or the "Company") (NASDAQ: TMDX) of a class action securities lawsuit.CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of TransMedics investors who were adversely affected by alleged securities fraud between February 28, 2023 and January 10, 2025. Follow the link below to get more information and be contacted by a member of our team:https://zlk.com/pslra-1/transmedics-gro ...

Core Viewpoint - Rosen Law Firm is reminding investors who purchased TransMedics Group, Inc. securities during the specified Class Period of the upcoming lead plaintiff deadline for a securities class action lawsuit [1][2]. Group 1: Class Action Details - The Class Period for the securities class action is from February 28, 2023, to January 10, 2025 [1]. - Investors may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [2]. - A lead plaintiff must file a motion with the Court by April 15, 2025, to represent other class members in the litigation [3]. Group 2: Law Firm Credentials - Rosen Law Firm has a strong track record in securities class actions, having achieved the largest settlement against a Chinese company at the time [4]. - The firm was ranked No. 1 by ISS Securities Class Action Services for the number of settlements in 2017 and has consistently ranked in the top 4 since 2013 [4]. - In 2019, the firm secured over $438 million for investors [4]. Group 3: Allegations Against TransMedics - The lawsuit alleges that TransMedics made materially false and misleading statements, including the use of kickbacks and fraudulent overbilling [5]. - It is claimed that TransMedics engaged in unsafe practices and lacked proper safety oversight, which increased regulatory scrutiny [5]. - The misleading statements about TransMedics' business and operations led to investor damages when the true details became public [5].

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In TransMedics To Contact Him Directly To Discuss Their OptionsIf you suffered losses exceeding $50,000 in TransMedics between February 23, 2023 and January 10, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310).[You may also click here for additional information]NEW YORK, April 3, 2025 / ...

SAN DIEGO, April 3, 2025 /PRNewswire/ -- The law firm of Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of TransMedics Group, Inc. (NASDAQ: TMDX) publicly traded securities between February 28, 2023 and January 10, 2025, both dates inclusive (the "Class Period"), have until Tuesday, April 15, 2025 to seek appointment as lead plaintiff of the TransMedics class action lawsuit.  Captioned Jewik v. TransMedics Group, Inc., No. 25-cv-10385 (D. Mass.), the TransMedics class action lawsuit ...